Jérôme Wacrenier

Enedis SA manages the public electricity distribution network. Its services include commissioning, repair, meter reading, and contract termination. The company was founded in 2008 and is headquartered in Paris, France.

EPIC Bpifrance provides legal services. The company is headquartered in Maisons-Alfort, France.

EDF Renouvelables SA engages in alternative energy distribution and generation. It extracts though wind, solar, hydro, biomass, biofuel, and biogas sources. The company was founded in 1990 and is headquartered in Nanterre, France.

EDF Energies Nouvelles Reparties SASU provides photovoltaic roofing and promotes renewable energy. It designs, markets, and installs solar panels. The company was founded on December 18, 2002 and is headquartered din Paris, France.

EDF Optimal Solution SAS provides energy management and audit services and is ultimately controlled by the Government of France. The company is based in Paris, France.

Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France.

Beaufour Ipsen Industrie SAS manufactures pharmaceutical products. The company was founded on July 22, 1942 and is headquartered in Dreux, France.

Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020.

eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France.

INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.

Part of Ernst & Young Global Ltd., Ernst & Young Audit SAS (France) is a French company that provides auditing and accounting services. The company is based in Courbevoie, France. Founded in 1987.

Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France.

Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.

Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France.

Part of Sanofi, Sanofi-Aventis Europe SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the company is Jérôme Contamine.

Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation.

Financière Verdi III is an investment holding private company based in Paris, France. The French company functions as an investment holding company.

Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Part of Sanofi, Sanofi Chimie SA is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Gentilly, France.